PENILAIAN FUNGSI HATI MELALUI PEMERIKSAAN SGOT DAN SGPT UNTUK DETEKSI DINI GANGGUAN HEPATOSELULER PADA DEWASA DI KELURAHAN SEMANAN
Keywords:
fungsi hati, HBsAg, Hepatitis B, pengabdian masyarakat, skrining kesehatanAbstract
Gangguan fungsi hati masih menjadi masalah kesehatan masyarakat yang memerlukan upaya deteksi dini melalui skrining berbasis komunitas. Kegiatan pengabdian kepada masyarakat ini bertujuan mengevaluasi fungsi hati menggunakan parameter SGOT dan SGPT pada masyarakat dewasa. Sebanyak 155 responden mengikuti kegiatan skrining dengan rerata usia 46,49 ± 10,29 tahun (rentang 19–80 tahun). Mayoritas peserta berjenis kelamin perempuan sebanyak 109 orang (70,3%), sedangkan laki-laki sebanyak 46 orang (29,7%). Hasil pemeriksaan menunjukkan rerata kadar SGOT sebesar 21,41 ± 5,85 U/L dan SGPT sebesar 20,67 ± 11,76 U/L yang secara umum masih berada dalam batas normal. Berdasarkan jenis kelamin, rerata kadar SGOT dan SGPT pada laki-laki masing-masing sebesar 22,02 U/L dan 23,00 U/L, sedangkan pada perempuan sebesar 21,16 U/L dan 19,69 U/L. Meskipun sebagian besar peserta memiliki fungsi hati dalam kisaran normal, beberapa peserta menunjukkan peningkatan kadar enzim hati yang memerlukan evaluasi lebih lanjut. Kegiatan skrining yang disertai edukasi mengenai pola makan sehat, aktivitas fisik, pengendalian berat badan, dan penggunaan obat secara bijak memberikan gambaran awal mengenai status kesehatan hati masyarakat serta mendukung upaya deteksi dini dan pencegahan gangguan fungsi hati
References
Allen, M. J., Tulleners, R., Brain, D., O’Beirne, J., Powell, E. E., Barnett, A., Valery, P. C., Kularatna, S., & Hickman, I. J. (2025). Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial). BMC Health Services Research, 25(1), 421. https://doi.org/10.1186/s12913-025-12580-5
Bawua, S. A., Ichihara, K., Keatley, R., Arko-Mensah, J., Ayeh-Kumi, P. F., Erasmus, R., & Fobil, J. (2022). Derivation of sex and age-specific reference intervals for clinical chemistry analytes in healthy Ghanaian adults. Clinical Chemistry and Laboratory Medicine (CCLM), 60(9), 1426–1439. https://doi.org/10.1515/cclm-2022-0293
Burra, P., Bizzaro, D., Gonta, A., Shalaby, S., Gambato, M., Morelli, M. C., Trapani, S., Floreani, A., Marra, F., Brunetto, M. R., Taliani, G., & Villa, E. (2021). Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH). Liver International, 41(8), 1713–1733. https://doi.org/10.1111/liv.14943
Cherubini, A., Della Torre, S., Pelusi, S., & Valenti, L. (2024). Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease. Trends in Molecular Medicine, 30(12), 1126–1136. https://doi.org/10.1016/j.molmed.2024.05.013
Gato, S., García-Fernández, V., Gil-Gómez, A., Rojas, Á., Montero-Vallejo, R., Muñoz-Hernández, R., & Romero-Gómez, M. (2024). Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome. European Cardiology Review, 19. https://doi.org/10.15420/ecr.2023.26
Hegazy, R. A. (2025). Unraveling Liver Cirrhosis: Bridging Pathophysiology to Innovative Therapeutics. Journal of Gastroenterology and Hepatology, 40(10), 2449–2462. https://doi.org/10.1111/jgh.70037
Hodge, A., & Crispin, P. (2010). Coagulopathy in liver disease: The whole is greater than the sum of its parts. Journal of Gastroenterology and Hepatology, 25(1), 1–2. https://doi.org/10.1111/j.1440-1746.2009.06027.x
Kočar, E., Blagotinšek Cokan, K., Kreft, T., Režen, T., & Rozman, D. (2025). The importance of sex dimorphism in liver metabolism and progressive liver diseases. Biology of Sex Differences, 17(1), 14. https://doi.org/10.1186/s13293-025-00811-7
Lisman, T., & Kwaan, H. (2015). Hemostatic Dysfunction in Liver Diseases. Seminars in Thrombosis and Hemostasis, 41(05), 445–446. https://doi.org/10.1055/s-0035-1550441
Liu, J., Tian, Y., Fu, X., Mu, C., Yao, M., Ni, Y., Liu, Y., & Li, Z. (2022). Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis. Chinese Medical Journal, 135(14), 1682–1691. https://doi.org/10.1097/CM9.0000000000002277
Maher, S., Dowdell, L., Zhang, L., & Zekry, A. (2021). Community screening identifies undiagnosed chronic liver disease in high‐risk populations. Journal of Gastroenterology and Hepatology, 36(8), 2255–2260. https://doi.org/10.1111/jgh.15473
Maurice, J., & Manousou, P. (2018). Non-alcoholic fatty liver disease. Clinical Medicine, 18(3), 245–250. https://doi.org/10.7861/clinmedicine.18-3-245
Melaram, R. (2021). Environmental Risk Factors Implicated in Liver Disease: A Mini-Review. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.683719
Oh, S.-Y., Cho, Y.-K., Kang, M.-S., Yoo, T.-W., Park, J.-H., Kim, H.-J., Park, D.-I., Sohn, C.-I., Jeon, W.-K., Kim, B.-I., Son, B.-H., & Shin, J.-H. (2006). The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism, 55(12), 1604–1609. https://doi.org/10.1016/j.metabol.2006.07.021
Perumpail, B. J., Khan, M. A., Yoo, E. R., Cholankeril, G., Kim, D., & Ahmed, A. (2017). Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World Journal of Gastroenterology, 23(47), 8263–8276. https://doi.org/10.3748/wjg.v23.i47.8263
Pustjens, J., Brouwer, W. P., Ayada, I., Janssen, H. L. A., & van Kleef, L. A. (2025). Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populations. World Journal of Gastroenterology, 31(37). https://doi.org/10.3748/wjg.v31.i37.107665
Qiu, J., Kuang, M., He, S., Yu, C., Wang, C., Huang, X., Sheng, G., & Zou, Y. (2023). Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1302322
Ranjbar, M., Shab-Bidar, S., Mohammadi, H., & Djafarian, K. (2025). Effect of Intermittent Fasting on Liver Function Tests: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrition Reviews, 83(3), e965–e979. https://doi.org/10.1093/nutrit/nuae070
Steinvil, A., Shapira, I., Ben-Bassat, O. K., Cohen, M., Vered, Y., Berliner, S., & Rogowski, O. (2010). The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovascular Diabetology, 9(1), 30. https://doi.org/10.1186/1475-2840-9-30
Tapper, E. B., & Serper, M. (2023). Screening for advanced liver disease in the general population. The Lancet, 402(10406), 941–943. https://doi.org/10.1016/S0140-6736(23)01412-5
Teng, M. L., Ng, C. H., Huang, D. Q., Chan, K. E., Tan, D. J., Lim, W. H., Yang, J. D., Tan, E., & Muthiah, M. D. (2023). Global incidence and prevalence of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology, 29(Suppl), S32–S42. https://doi.org/10.3350/cmh.2022.0365
